Symmetry Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $217K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $819K | Hold |
|
|||||
|
2024
Q1 | $750K | Sell |
|
|||||
|
2023
Q4 | $770K | Sell |
|
|||||
|
2023
Q3 | $974K | Sell |
|
|||||
|
2023
Q2 | $967K | Sell |
|
|||||
|
2023
Q1 | $1.44M | Buy |
|
|||||
|
2022
Q4 | $1.14M | Sell |
|
|||||
|
2022
Q3 | $1.15M | Buy |
|
|||||
|
2022
Q2 | $904K | Sell |
|
|||||
|
2022
Q1 | $1.77M | Buy |
|
|||||
|
2021
Q4 | $565K | Hold |
|
|||||
|
2021
Q3 | $493K | Buy |
|
|||||
|
2021
Q2 | $455K | Buy |
|
|||||
|
2021
Q1 | $281K | Sell |
|
|||||
|
2020
Q4 | $547K | Sell |
|
|||||
|
2020
Q3 | $1.14M | Buy |
|
|||||
|
2020
Q2 | $715K | Buy |
|